These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 999320)

  • 1. Long-term triamcinolone acetonide therapy.
    Arnold HL
    Arch Dermatol; 1976 Sep; 112(9):1327. PubMed ID: 999320
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term intramuscular administration of triamcinolone acetonide.
    Mikhail GR; Sweet LC; Mellinger RC
    Arch Dermatol; 1977 Jan; 113(1):111. PubMed ID: 831617
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term treatment of disseminated neurodermatitis using depot triamcinolone-acetonide (Volon A 40)].
    Weitgasser H
    Z Haut Geschlechtskr; 1970 Jan; 45(1):63-6. PubMed ID: 5427375
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS; Vernon SA; Negi A
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cataract surgery after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring RF
    Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK; Chung EJ; Kwon OW; Lee JH; Koh HJ
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term intramuscular administration of triamcinolone acetonide. Effect on the hypothalamic-pituitary-adrenal axis.
    Carson TE; Daane TA; Weinstein RL
    Arch Dermatol; 1975 Dec; 111(12):1585-7. PubMed ID: 1200663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataract formation and other complications of intravitreal triamcinolone for macular edema.
    Thompson JT
    Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone.
    Spaide RF
    Ophthalmology; 2008 Aug; 115(8):1436; author reply 1436-7. PubMed ID: 18675704
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adverse effect of the long-term use of triamcinolone acetonide in patients with bronchial asthma].
    Madalińska M; Droszcz W; Piotrowska B
    Pol Tyg Lek; 1988 May; 43(21):685-8. PubMed ID: 3226975
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis.
    Welch MJ; Bronsky E; Findlay S; Pearlman DS; Southern DL; Storms WW; Weakley S
    Clin Ther; 1994; 16(2):253-62. PubMed ID: 8062320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
    Gillies MC; Kuzniarz M; Craig J; Ball M; Luo W; Simpson JM
    Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
    Kim SY; Yang J; Lee YC; Park YH
    J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.